Girinsky T, Ghalibafian M, Paumier A
Département des radiations, institut de cancérologie Gustave-Roussy, 114, rue Édouard-Vaillant, 94805 Villejuif, France.
Cancer Radiother. 2011 Oct;15(6-7):546-8. doi: 10.1016/j.canrad.2011.06.004. Epub 2011 Aug 31.
IMRT is a seducing treatment option in patients with Hodgkin lymphoma mediastinal masses due to the complex form of the tumour masses and their proximity to organs at risk such as the heart and the coronary arteries. This treatment delivery technique remains risky owing to respiratory movements and heart beats. The concomitant use of IMRT and respiratory gating is enticing, but a number of theoretical and practical hurdles remain to be resolved before it can be used in clinical daily practice.
由于肿瘤块的复杂形态及其与心脏和冠状动脉等危险器官的接近程度，调强放射治疗（IMRT）是霍奇金淋巴瘤纵隔肿块患者一种诱人的治疗选择。由于呼吸运动和心跳，这种治疗实施技术仍然存在风险。IMRT与呼吸门控的联合使用很有吸引力，但在临床日常实践中应用之前，仍有许多理论和实际障碍有待解决。
